Genetic Analysis of a Unique Human Immunodeficiency Virus Type 1 (HIV-1) with a Primer Binding Site Complementary to tRNA(Met) Supports a Role for U5-PBS Stem-Loop RNA Structures i...

Por Kang, Sang-Moo, Morrow, Casey D.
Publicado em 1999

Enhancement of Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus

Por Kang, Sang-Moo, Compans, Richard W.
Publicado em 2003

Novel vaccines against influenza viruses

Por Kang, Sang-Moo, Song, Jae-Min, Compans, Richard W.
Publicado em 2011

Virus-like particles as universal influenza vaccines

Por Kang, Sang-Moo, Kim, Min-Chul, Compans, Richard W
Publicado em 2012

Protective CD8 T cell mediated immunity against influenza A virus infection following influenza virus-like particle vaccination

Por Hemann, Emily A., Kang, Sang-Moo, Legge, Kevin L.
Publicado em 2013

Microneedle and mucosal delivery of influenza vaccines

Por Kang, Sang-Moo, Song, Jae-Min, Kim, Yeu-Chun
Publicado no Expert Rev Vaccines (2012)

Oral vaccination with inactivated influenza vaccine induces cross-protective immunity

Por Quan, Fu-Shi, Compans, Richard W., Kang, Sang-Moo
Publicado no Vaccine (2011)

Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B

Por Kang, Sang-Moo, Yao, Qizhi, Guo, Lizheng, Compans, Richard W.
Publicado em 2003

Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies

Por Mohan, Teena, Berman, Zachary, Kang, Sang-Moo, Wang, Bao-Zhong
Publicado no Sci Rep (2018)

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

Por Quan, Fu-Shi, Huang, Chunzi, Compans, Richard W., Kang, Sang-Moo
Publicado em 2007

Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice

Por Quan, Fu-Shi, Vunnava, Aswani, Compans, Richard W., Kang, Sang-Moo
Publicado em 2010

Cutaneous immunization: an evolving paradigm in influenza vaccines

Por Gill, Harvinder S, Kang, Sang-Moo, Quan, Fu-Shi, Compans, Richard W
Publicado em 2014

Preferential Completion of Human Immunodeficiency Virus Type 1 Proviruses Initiated with tRNA(3)(Lys) rather than tRNA(1,2)(Lys)

Por Zhang, Zhijun, Yu, Qin, Kang, Sang-Moo, Buescher, James, Morrow, Casey D.
Publicado em 1998

Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens

Por Kang, Sang-Moo, Guo, Lizheng, Yao, Qizhi, Skountzou, Ioanna, Compans, Richard W.
Publicado em 2004

Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization

Por Quan, Fu-Shi, Compans, Richard W., Nguyen, Huan H., Kang, Sang-Moo
Publicado em 2008

Influenza vaccines based on virus-like particles

Por Kang, Sang-Moo, Song, Jae-Min, Quan, Fu-Shi, Compans, Richard W.
Publicado em 2009

The osmotic stress response of split influenza vaccine particles in an acidic environment

Por Choi, Hyo-Jick, Kim, Min-Chul, Kang, Sang-Moo, Montemagno, Carlo D.
Publicado em 2013

Human Immunodeficiency Virus-Like Particles Activate Multiple Types of Immune Cells

Por Sailaja, Gangadhara, Skountzou, Ioanna, Quan, Fu-Shi, Compans, Richard W., Kang, Sang-Moo
Publicado em 2007

Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine

Por Pearton, Marc, Pirri, Daniela, Kang, Sang-Moo, Compans, Richard W, Birchall, James C
Publicado em 2013

Korean Red Ginseng Slows Depletion of CD4 T Cells in Human Immunodeficiency Virus Type 1-Infected Patients

Por Sung, Heungsup, Kang, Sang-Moo, Lee, Moo-Song, Kim, Tai Gyu, Cho, Young-Keol
Publicado em 2005